- Home
- TRAW
TRAW
TRAWS PHARMA INC
as 05-15-2025 4:00pm EST
Stocks
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | NEWTOWN |
| Market Cap: | 7.8M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 128.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -35.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.32 - $19.44 | Next Earning Date: | 05-15-2025 |
| Revenue: | $226,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 3.81% | Revenue Growth (next year): | 30.43% |
Latest TRAWS PHARMA INC News
TRAW Breaking Stock News: Dive into TRAW Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
GlobeNewswire
2 months ago
Traws Pharma Reports Full Year 2024 Results and Business Highlights
GlobeNewswire
2 months ago
Traws Pharma Announces Management Updates
GlobeNewswire
2 months ago
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
GlobeNewswire
2 months ago
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
GlobeNewswire
2 months ago
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
GlobeNewswire
2 months ago
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
GlobeNewswire
2 months ago
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
Compare TRAW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TRAW TRAWS PHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.